ARCHIVES

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

June issue of Business & Regulatory Report included.

July 2, 2004

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

Childhood Cancer Foundation Names New President

September 20, 2002

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

In Brief: Peter Vogt Names Bristol-Myers Winner; Other Awards: Koop, Weinberg, Wynder, Longmire

March 24, 1989